Use of immune checkpoint inhibitors in cancer patients with pre-existing sarcoidosis
Use of immune checkpoint inhibitors in cancer patients with pre-existing sarcoidosis
About this item
Full title
Author / Creator
Publisher
London, UK: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London, UK: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
To evaluate adverse events in cancer patients with pre-existing sarcoidosis receiving immune checkpoint inhibitors (ICIs).
We retrospectively reviewed cancer patients with sarcoidosis who underwent treatment with ICI to determine frequency of sarcoidosis flares.
32 patients with sarcoidosis received ICIs The median time to ICI initiation was...
Alternative Titles
Full title
Use of immune checkpoint inhibitors in cancer patients with pre-existing sarcoidosis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7983044
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7983044
Other Identifiers
ISSN
1750-743X
E-ISSN
1750-7448
DOI
10.2217/imt-2020-0272
